about
Does HCV Patients Who Have BCL2 43Ala Genotype and Normal GH1 Levels Can Achieve Response to IFN Based Therapy?Correlation and multiple regression analyses of pituitary growth hormone and hepatic activities in hepatitis C infection and interferon response.The impact of digestive and colon drugs on the human hormones profile."P53 codon 72 single base substitution in viral hepatitis C and hepatocarcinoma incidences".TRAIL combinations: The new 'trail' for cancer therapy (Review).Recent advances and future directions in the management of hepatitis C infections.Synthesis, Characterization, and Evaluation of Cytotoxic Effects of Novel Hybrid Steroidal Heterocycles as PEG Based NanoparticlesCS-PEG decorated PLGA nano-prototype for delivery of bioactive compounds: A novel approach for induction of apoptosis in HepG2 cell line.Nano-Micelle of Moringa Oleifera Seed Oil Triggers Mitochondrial Cancer Cell ApoptosisDoes interferon and ribavirin combination therapy ameliorate growth hormone deficiency in HCV genotype-4 infected patients?Calcium, a Cell Cycle Commander, Drives Colon Cancer Cell Diffpoptosis.Potential impact of curcumin and taurine on human hepatoma cells using Huh-7 cell line.The potential impact of P53 and APO-1 genetic polymorphisms on hepatitis C genotype 4a susceptibility.Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients.How does long term exposure to base stations and mobile phones affect human hormone profiles?Effect of alpha lipoic acid on in vitro development of bovine secondary preantral follicles.Moringa oleifera Root Induces Cancer Apoptosis more Effectively than Leave Nanocomposites and Its Free CounterpartEvaluation of the Antiproliferative Activity of Some Nanoparticulate Essential Oils Formulated in Microemulsion on Selected Human Carcinoma Cell Lines.Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis.IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.Taribavirin and 5-Fluorouracil-Loaded Pegylated-Lipid Nanoparticle Synthesis, p38 Docking, and Antiproliferative Effects on MCF-7 Breast Cancer.Selenium Nanoparticles Induce the Chemo-Sensitivity of Fluorouracil Nanoparticles in Breast and Colon Cancer Cells.Role of mitochondria in rescuing glycolytically inhibited subpopulation of triple negative but not hormone-responsive breast cancer cellsSynthesis and Evaluation of Novel Cholestanoheterocyclic Steroids as Anticancer AgentsSynthesis of novel hybrid hetero-steroids: Molecular docking study augmented anti-proliferative properties against cancerous cellsEnhanced mesenchymal stem cell proliferation through complexation of selenium/titanium nanocompositesP53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapySelenium Overcomes Doxorubicin Resistance in Their Nano-platforms Against Breast and Colon CancersViramidine-Loaded Galactosylated Nanoparticles Induce Hepatic Cancer Cell Apoptosis and Inhibit AngiogenesisBevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer CellsRaloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cellsNanotechnological Applications Hold a Pivotal Position in Boosting Stem Cells Osteogenic Activity: In Vitro and In Vivo StudiesImproving Anti-Cancer Potentiality and Bioavailability of Gallic Acid by Designing Polymeric Nanocomposite Formulation
P50
Q36336416-337F08B1-A365-42AB-A07D-1FBCC480F063Q37199380-CCAB2A70-6C2E-493F-9154-4374D5A331EDQ37199422-F627FDE2-1628-482A-896D-DB8DC11108A4Q37522021-5C6DF637-2763-4282-AD2B-B0BAAFDC60E8Q37719944-2782706C-1548-4506-9B14-279139B5EA2AQ38247000-B7D0AEC2-0DDB-48E1-950C-E110B17E3948Q38657743-D5E5FAC3-A16D-4474-A8C0-ECFD7B25063BQ38703052-0C943F63-A06C-48F8-BFCD-20268E13043BQ38723872-4F3EE380-F706-417A-87A0-02DA1A094273Q38995169-4747FFC3-5A2B-4563-88FF-88B806ED37D4Q39114182-2097DFBF-8998-40C1-81D9-0D4E2878F01EQ39317583-B91F8BA8-E32A-4C8F-A213-AA384AE3CFCCQ42200919-11BA2751-F947-4CA7-A012-9E014F8587A7Q45370483-8157184B-2519-4A82-A3CD-AB335EFAD2D9Q46565112-FBDD67E9-83C5-4B7E-8085-6AF582924A33Q46779620-901B9080-1907-4EF1-A0B7-BB08757935A6Q47104969-0CD50072-1A88-4D09-B325-13B89B34A327Q50108166-568BEBC2-788B-4AB2-88BD-3C8013420FBAQ51255265-FE2F0F78-119B-48DF-BDC6-0792F69B3378Q51596495-4C04F70D-33ED-4723-9F62-B3E74193FF2CQ52682158-8BD2E836-D0DF-4A5D-9A19-59A4F6820AE1Q53683390-E1FEBAAD-157C-44A1-AA46-1823D72DC30CQ90262361-8EA222C5-86A0-44E2-8F21-4594E5B29ACBQ90912643-CC5C8597-BAE8-4900-86ED-61EA65180B01Q91060518-69C4775E-C24C-488F-804F-EB0AE4F7F34DQ91476988-362E2467-6B2E-406E-8101-7B5333FE3B86Q91792038-301BBF37-6520-4B2F-8A7B-217408658E9FQ91841517-9AE3F7AD-8EE9-487E-A8DD-49425DB5FF27Q92191469-8A247886-18AF-4275-AFC3-8DD87E6186FBQ92218750-6EC2F66B-CCB8-4E78-A39A-E13BB70DC440Q92419820-9E64E6DA-0016-491D-91E0-BA41596BEDF3Q92515395-B2DE72A3-0333-4569-BD7B-AAD861318754Q93376671-A52D6AB7-C17A-4C86-97E0-E71F304540D0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ahmed A Abd-Rabou
@ast
Ahmed A Abd-Rabou
@en
Ahmed A Abd-Rabou
@es
Ahmed A Abd-Rabou
@nl
type
label
Ahmed A Abd-Rabou
@ast
Ahmed A Abd-Rabou
@en
Ahmed A Abd-Rabou
@es
Ahmed A Abd-Rabou
@nl
prefLabel
Ahmed A Abd-Rabou
@ast
Ahmed A Abd-Rabou
@en
Ahmed A Abd-Rabou
@es
Ahmed A Abd-Rabou
@nl
P106
P1153
36991603200
P21
P31
P496
0000-0002-9875-7591